Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition for treating facial neuritis

A technology for facial neuritis and composition, which is applied in the field of medicine to achieve the effects of good local absorption, enhancement of muscle strength, and promotion of functional recovery

Inactive Publication Date: 2015-01-28
孟凯涛
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Western medicine mainly uses hormones, vitamins and vasodilators, and its curative effect is limited

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

experiment example

[0016] Diagnostic criteria

[0017] It meets the following three points: (1) Facial expression muscles on one side are paralyzed, unable to wrinkle forehead or frown, disappear forehead lines, enlarge eye fissures, incomplete or unable to close. (2) The nasolabial fold on the affected side becomes shallow or disappears, the corners of the mouth droop, the corners of the mouth tilt to the side of the key when the teeth are exposed, and the corners of the mouth leak air when the cheeks are bulging. (3) It may be accompanied by tears, tinnitus but lack of consciousness, and limb paralysis. The severity of facial paralysis is judged by referring to the House-brackmann grading scale: grades I to III of the grading scale are mild facial paralysis, and grades IV to VI are severe facial paralysis. The first 10 days of onset are called the acute phase, the next month is called the middle phase, and after the middle phase is called the late phase.

[0018] exclusion criteria

[0019]...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicine composition for treating facial neuritis. The medicine composition is prepared from the following substances in parts by weight: 200-500 parts of lacerate wood fern rhizomes, 200-300 parts of columbine, 200-300 parts of bauhinia brachycarpa, 100-300 parts of phlomis younghusbandii, 100-300 parts of twin-sorus fern, 100-300 parts of ivylike merremia seeds, 100-300 parts of abutilon indicum, 100-500 parts of phlomis umbrosa and 100-500 parts of frost sargentgloryvine stems. The medicine composition disclosed by the invention interacts to have synergistic effects, has better efficacies of clearing and activating the channels and collaterals, removing obstruction, subduing swelling and promoting blood circulation for removing blood stasis, has good medicine partial absorption effect, can enhance the myodynamia of paralytic muscle groups, and promotes the restoration of functions of facial palsy muscle groups.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a pharmaceutical composition for treating facial neuritis. Background technique [0002] Facial neuritis not only brings pain to the patient, but also seriously affects the image, produces huge psychological pressure, and leads to inferiority complex. Modern medicine claims that primary disease is peripheral facial neuritis, which is mostly caused by facial nerve ischemic edema caused by cold stimulation, bacteria and virus infection. Western medicine treatment mainly adopts hormone, vitamin and vasodilator, and its curative effect has bigger limitation. Contents of the invention [0003] The object of the present invention is to provide a pharmaceutical composition for treating facial neuritis. [0004] In order to realize the object of the present invention, the present invention provides a kind of pharmaceutical composition for the treatment of facial neuritis, and it is made of th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/71A61P25/02
CPCA61K36/11A61K9/7023A61K36/185A61K36/39A61K36/48A61K36/486A61K36/53A61K36/71A61K2300/00
Inventor 孟凯涛
Owner 孟凯涛
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products